Colorectal Cancer Screening Guidelines
Average-risk adults should begin colorectal cancer screening at age 45 with either a high-sensitivity stool-based test or a structural examination, with all positive non-colonoscopy screening tests followed by timely colonoscopy. 1
Screening Age Recommendations
- Average-risk adults should begin screening at age 45 1
- Continue regular screening through age 75 for those in good health with life expectancy >10 years 1
- For adults aged 76-85, screening decisions should be based on patient preferences, life expectancy, health status, and prior screening history 1
- Screening is generally not recommended for adults over age 85 1
- High-risk individuals (first-degree relative with colorectal cancer or advanced adenoma diagnosed before age 60) should begin screening at age 40 or 10 years before the youngest affected relative's diagnosis 1, 2
Recommended Screening Tests
Tier 1 (Preferred) Tests
Tier 2 Tests
- High-sensitivity guaiac-based fecal occult blood test (HSgFOBT) annually 1
- Multitarget stool DNA test (mt-sDNA/FIT-DNA) every 3 years 1
- CT colonography every 5 years 1, 4
- Flexible sigmoidoscopy every 5 years 1, 4
Risk Stratification Approach
- For average-risk individuals: Begin screening at age 45 1
- For African Americans: Begin screening at age 45 due to higher disease burden 1, 5
- For high-risk individuals (family history): Begin screening at age 40 or 10 years before the youngest affected relative's diagnosis 1, 2
- For those with two or more first-degree relatives with colorectal cancer: Begin screening earlier and use colonoscopy 5
Implementation Considerations
- All positive results from non-colonoscopy screening tests must be followed up with timely colonoscopy 1
- Patient preference should be considered when selecting a screening method 1
- Quality indicators for colonoscopy should be monitored (cecal intubation rates, withdrawal time, adenoma detection rates) 1
When to Stop Screening
- Discontinue screening in adults aged 75+ who are up-to-date with prior negative screening results 1, 6
- For adults aged 76-85, individualize decisions based on overall health status, prior screening history, and life expectancy 1
- Screening is not recommended for adults over age 85 1
Common Pitfalls and Caveats
- Failure to follow up positive stool-based tests with colonoscopy negates the benefit of screening 1
- Inadequate bowel preparation can reduce colonoscopy effectiveness 1
- Discontinuing screening too early in healthy individuals or continuing too long in those with limited life expectancy can lead to unnecessary risks 1
- Variability in colonoscopy quality can significantly impact screening effectiveness 1
- Rising colorectal cancer incidence in persons under age 50 necessitates thorough diagnostic evaluation of young persons with suspected colorectal bleeding 3
Screening Test Selection Strategy
- Consider a sequential approach: offer colonoscopy first, then FIT to patients who decline colonoscopy 3
- A risk-stratified approach is appropriate: FIT screening in populations with estimated low prevalence of advanced neoplasia and colonoscopy screening in high prevalence populations 3
- The most recent guidelines discourage the use of Septin9 serum assay for screening 3